propinonyl-l-carnitine Glycin Propionyl L-carnitine Hcl Cas 423152-20-9 Gplc Glycine Propionyl-l-carnitine Chemical structure of L-carnitine and

10.1128/JB.182.18.5139-5146.2000 [DOI] [PMC free article] [PubMed] [Google Scholar] Prabhu P

Neurofilament light chain levels indicate acute axonal damage under bortezomib treatment

These drugs were utilized as keywords to retrieve reported adverse drug events (ADEs) from the FAERS database for the period spanning from 1 January 2013, to 30 September 2024

ADZENYS XR-ODT (amphetamine extended-release orally disintegrating tablet) contains a 3 to 1 ratio of d- to l-amphetamine, a central nervous system stimulant

All investigators were involved in the study design and will continue to have a role in result analysis and writing of the manuscript

Based on the plethora of symptoms affecting different organs/systems, PASC-affected population could be categorized into four different clusters or sub-phenotypes: Sub-phenotype-1 (33.8%) with cardiac and renal manifestations, Sub-phenotype-2 (32.8%) with respiratory, sleep and anxiety disorders, Sub-phenotype-3 (23.4%) with skeleton-muscular and nervous disorders, and Sub-phenotype-4 (10.1%) with digestive and pulmonary dysfunctions 123,136